Literature DB >> 19320567

High HIV Type 1 prevalence and wide genetic diversity with dominance of recombinant strains but low level of antiretroviral drug-resistance mutations in untreated patients in northeast Gabon, Central Africa.

Armel Mintsa-Ndong1, Melanie Caron, Jean-Christophe Plantier, Maria Makuwa, Simon Le Hello, Valerie Courgnaud, Pierre Roques, Mirdad Kazanji.   

Abstract

The northeast of Gabon, central Africa is characterized by high population density and a high rate of immigration from the surrounding countries. To determine the prevalence, circulating subtypes, and antiretroviral resistance mutations of HIV-1, 810 blood samples were collected from the general population of the two main cities (Oyem and Makokou) of this region. Of these, 61 (7.5%) were found to be positive for HIV-1. Analysis of the env (gp120), pol, and gag (p24) sequences as well as phylogenetic analyses showed at least eight different viral lineages. The most prevalent strains were CRF02 recombinants, followed by subtypes A, D, and C. The remaining strains were found to be F, J, G, and also, for the first time in Gabon, the recombinant form CRF11cpx. Analysis of antiretroviral drug-resistance mutations in protease and reverse transcriptase from this untreated population showed a low level of specific mutations. These mutations were associated with subtype polymorphism rather than with resistance to antiretroviral drugs. The wide diversity and the emergence of recombinant strains are in accordance with the rapid spread of new HIV strains in the population and, thus, the dynamic evolution of the epidemic.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320567     DOI: 10.1089/aid.2008.0223

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

Review 1.  TB and HIV in the Central African region: current knowledge and knowledge gaps.

Authors:  S Janssen; M A M Huson; S Bélard; S Stolp; N Kapata; M Bates; M van Vugt; M P Grobusch
Journal:  Infection       Date:  2013-12-06       Impact factor: 3.553

2.  Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, central Africa.

Authors:  Mélanie Caron; Sonia Etenna Lekana-Douki; Maria Makuwa; Guy-Patrick Obiang-Ndong; Olivia Biba; Dieudonné Nkoghé; Mirdad Kazanji
Journal:  BMC Infect Dis       Date:  2012-03-20       Impact factor: 3.090

3.  Evaluation of HIV-1 rapid diagnostic tests in the context of viral genetic diversity in Libreville (Gabon).

Authors:  Yann Vital Sima Biyang; Soulemane Parkouda; Berthold Bivigou-Mboumba; Berthe Amélie Iroungou; Augustin Mouinga Ondeme; Cyrille Bisseye
Journal:  Pan Afr Med J       Date:  2022-07-11

4.  Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon.

Authors:  Florian Liégeois; Caroline Vella; Sabrina Eymard-Duvernay; Jeanne Sica; Laurent Makosso; Augustin Mouinga-Ondémé; Arnaud Delis Mongo; Vanina Boué; Christelle Butel; Martine Peeters; Jean-Paul Gonzalez; Eric Delaporte; François Rouet
Journal:  J Int AIDS Soc       Date:  2012-11-28       Impact factor: 5.396

5.  Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain.

Authors:  Gonzalo Yebra; Miguel de Mulder; África Holguín
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.